Oxford BioMedica (GB:OXB) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Oxford Biomedica plc has disclosed its total voting rights with 105,323,963 ordinary shares, indicating no treasury-held shares as of July 31, 2024. This information is crucial for shareholders to assess their notification requirements for shareholding changes under the FCA’s rules. The company, a pioneer in cell and gene therapy, offers extensive viral vector development and manufacturing services to its global pharmaceutical and biotech partners.
For further insights into GB:OXB stock, check out TipRanks’ Stock Analysis page.